Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
The Prostate
|
September 25, 2004
Combined external beam radiotherapy and Pd-103 brachytherapy boost improves biochemical failure free survival in patients with clinically localized prostate cancer: results of a matched pair analysis
Anu M Singh, Gregory Gagnon, Brian Collins, et al.
Frontiers in Immunology
|
November 28, 2022
Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses
Xiaoming Sun, Ce Gao, Ke Zhao, et al.
The American Journal of Medicine
|
November 12, 2020
Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia
Hasan K Siddiqi, Brittany Weber, Guohai Zhou, et al.
Open Forum Infectious Diseases
|
February 16, 2022
Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
James Regan, James P Flynn, Manish C Choudhary, et al.
Scientific Reports
|
October 19, 2023
Viral and immunologic evaluation of smokers with severe COVID-19
Joseph Vecchio, James Regan, Yuting Jiang, et al.
Seminars in Oncology
|
February 24, 2005
Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification
Steven K Seung, John W Smith, John Molendyk, et al.
Behavioral Medicine (Washington, D.C.)
|
December 28, 2010
Use and evaluation of a CD-ROM-based decision aid for prostate cancer treatment decisions
Kathryn L Taylor, Kimberly M Davis, Tara Lamond, et al.
Science Translational Medicine
|
May 10, 2023
Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption
Elmira Esmaeilzadeh, Behzad Etemad, Christy L Lavine, et al.
The Journal of Infectious Diseases
|
January 13, 2022
SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise
Lydia L Shook, Sara Brigida, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 24, 2021
Type I, II, and III interferon signatures correspond to COVID-19 disease severity
Myung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
The Prostate
|
September 25, 2004
Combined external beam radiotherapy and Pd-103 brachytherapy boost improves biochemical failure free survival in patients with clinically localized prostate cancer: results of a matched pair analysis
Anu M Singh, Gregory Gagnon, Brian Collins, et al.
Frontiers in Immunology
|
November 28, 2022
Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses
Xiaoming Sun, Ce Gao, Ke Zhao, et al.
The American Journal of Medicine
|
November 12, 2020
Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia
Hasan K Siddiqi, Brittany Weber, Guohai Zhou, et al.
Open Forum Infectious Diseases
|
February 16, 2022
Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
James Regan, James P Flynn, Manish C Choudhary, et al.
Scientific Reports
|
October 19, 2023
Viral and immunologic evaluation of smokers with severe COVID-19
Joseph Vecchio, James Regan, Yuting Jiang, et al.
Seminars in Oncology
|
February 24, 2005
Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification
Steven K Seung, John W Smith, John Molendyk, et al.
Behavioral Medicine (Washington, D.C.)
|
December 28, 2010
Use and evaluation of a CD-ROM-based decision aid for prostate cancer treatment decisions
Kathryn L Taylor, Kimberly M Davis, Tara Lamond, et al.
Science Translational Medicine
|
May 10, 2023
Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption
Elmira Esmaeilzadeh, Behzad Etemad, Christy L Lavine, et al.
The Journal of Infectious Diseases
|
January 13, 2022
SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise
Lydia L Shook, Sara Brigida, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 24, 2021
Type I, II, and III interferon signatures correspond to COVID-19 disease severity
Myung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
Page
of 6